Search Results - "Carbonaro, Theresa M"

Refine Results
  1. 1

    Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [ 11 C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation by Barrett, Frederick S, Zhou, Yun, Carbonaro, Theresa M, Roberts, Joshua M, Smith, Gwenn S, Griffiths, Roland R, Wong, Dean F

    Published in Frontiers in neuroergonomics (20-01-2022)
    “…Psilocybin (a serotonin 2A, or 5-HT , receptor agonist) has shown preliminary efficacy as a treatment for mood and substance use disorders. The current report…”
    Get full text
    Journal Article
  2. 2

    Neuropharmacology of N , N -dimethyltryptamine by Carbonaro, Theresa M, Gatch, Michael B

    Published in Brain research bulletin (01-09-2016)
    “…Highlights • N , N -dimethyltryptamine (DMT) is an endogenous compound in both plants and animals. • Subjective effects of DMT are mediated by several…”
    Get full text
    Journal Article
  3. 3

    Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences by Carbonaro, Theresa M., Johnson, Matthew W., Hurwitz, Ethan, Griffiths, Roland R.

    Published in Psychopharmacology (01-02-2018)
    “…Rationale Although psilocybin and dextromethorphan (DXM) are hallucinogens, they have different receptor mechanisms of action and have not been directly…”
    Get full text
    Journal Article
  4. 4

    Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences by Carbonaro, Theresa M, Bradstreet, Matthew P, Barrett, Frederick S, MacLean, Katherine A, Jesse, Robert, Johnson, Matthew W, Griffiths, Roland R

    Published in Journal of psychopharmacology (Oxford) (01-12-2016)
    “…Acute and enduring adverse effects of psilocybin have been reported anecdotally, but have not been well characterized. For this study, 1993 individuals (mean…”
    Get full text
    Journal Article
  5. 5

    Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan by Carbonaro, Theresa M., Johnson, Matthew W., Griffiths, Roland R.

    Published in Psychopharmacology (01-08-2020)
    “…Rationale Although both psilocybin and dextromethorphan (DXM) produce psychedelic-like subjective effects, rates of non-medical use of psilocybin are…”
    Get full text
    Journal Article
  6. 6

    Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches by Garcia-Romeu, Albert, Barrett, Frederick S, Carbonaro, Theresa M, Johnson, Matthew W, Griffiths, Roland R

    Published in Journal of psychopharmacology (Oxford) (01-04-2021)
    “…Background: Growing evidence suggests psilocybin, a naturally occurring psychedelic, is a safe and promising pharmacotherapy for treatment of mood and…”
    Get full text
    Journal Article
  7. 7

    Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition by Barrett, Frederick S., Carbonaro, Theresa M., Hurwitz, Ethan, Johnson, Matthew W., Griffiths, Roland R.

    Published in Psychopharmacology (01-10-2018)
    “…Objectives Classic psychedelics (serotonin 2A receptor agonists) and dissociative hallucinogens (NMDA receptor antagonists), though differing in pharmacology,…”
    Get full text
    Journal Article
  8. 8

    Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents by Shaw, Hannah E, Patel, Dylan R, Gannon, Brenda M, Fitzgerald, Lauren R, Carbonaro, Theresa M, Johnson, Chad R, Fantegrossi, William E

    “…Abuse of novel arylcyclohexylamines (ACX) poses risks for toxicities, including adverse neurocognitive effects. In vivo effects of ring-substituted analogs of…”
    Get more information
    Journal Article
  9. 9

    Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate by Carbonaro, Theresa M., Nguyen, Vien, Forster, Michael J., Gatch, Michael B., Prokai, Laszlo

    Published in Neuropharmacology (01-09-2020)
    “…Carisoprodol (Soma®) is a centrally-acting skeletal-muscle relaxant frequently prescribed for treatment of acute musculoskeletal conditions. Carisoprodol's…”
    Get full text
    Journal Article
  10. 10

    Hippocampal microglial activation and glucocorticoid receptor down-regulation precipitate visceral hypersensitivity induced by colorectal distension in rats by Zhang, Gongliang, Zhao, Bing-Xue, Hua, Rong, Kang, Jie, Shao, Bo-Ming, Carbonaro, Theresa M., Zhang, Yong-Mei

    Published in Neuropharmacology (01-03-2016)
    “…Visceral hypersensitivity is a common characteristic in patients suffering from irritable bowel syndrome (IBS) and other disorders with visceral pain. Although…”
    Get full text
    Journal Article
  11. 11

    Discriminative Stimulus Effects of Substituted Tryptamines in Rats by Gatch, Michael B, Hoch, Adam, Carbonaro, Theresa M

    Published in ACS pharmacology & translational science (09-04-2021)
    “…Novel synthetic compounds have been available for decades as quasi-legal alternatives to controlled substances. The hallucinogen-like effects of eight novel…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Discriminative stimulus effects of N,N-diisopropyltryptamine by Carbonaro, Theresa M, Forster, Michael J, Gatch, Michael B

    Published in Psychopharmacology (01-03-2013)
    “…Rationale Serotonergic hallucinogens such as (+)-lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT) produce distinctive visual effects, whereas the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice by Carbonaro, Theresa M., Eshleman, Amy J., Forster, Michael J., Cheng, Kejun, Rice, Kenner C., Gatch, Michael B.

    Published in Psychopharmacology (01-01-2015)
    “…Rationale Serotonin 5-HT 2A and 5-HT 2C receptors are thought to be the primary pharmacological mechanisms for serotonin-mediated hallucinogenic drugs, but…”
    Get full text
    Journal Article
  17. 17

    The role of 5-HT sub(2A), 5-HT sub(2C) and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice by Carbonaro, Theresa M, Eshleman, Amy J, ster, Michael J, Cheng, Kejun, Rice, Kenner C, Gatch, Michael B

    Published in Psychopharmacology (01-01-2015)
    “…Rationale: Serotonin 5-HT sub(2A) and 5-HT sub(2C) receptors are thought to be the primary pharmacological mechanisms for serotonin-mediated hallucinogenic…”
    Get full text
    Journal Article
  18. 18

    The role of 5-[HT.sub.2A], 5-[HT.sub.2C] and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice by Carbonaro, Theresa M, Eshleman, Amy J, Forster, Michael J, Cheng, Kejun, Rice, Kenner C, Gatch, Michael B

    Published in Psychopharmacology (01-01-2015)
    “…Rationale Serotonin 5-[HT.sub.2A] and 5-[HT.sub.2C] receptors are thought to be the primary pharmacological mechanisms for serotonin-mediated hallucinogenic…”
    Get full text
    Journal Article
  19. 19

    The role of 5-HT^sub 2A^, 5-HT^sub 2C^ and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice by Carbonaro, Theresa M, Eshleman, Amy J, ster, Michael J, Cheng, Kejun, Rice, Kenner C, Gatch, Michael B

    Published in Psychopharmacology (01-01-2015)
    “…Serotonin 5-HT^sub 2A^ and 5-HT^sub 2C^ receptors are thought to be the primary pharmacological mechanisms for serotonin-mediated hallucinogenic drugs, but…”
    Get full text
    Journal Article
  20. 20

    The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice by Carbonaro, Theresa M, Eshleman, Amy J, Forster, Michael J, Cheng, Kejun, Rice, Kenner C, Gatch, Michael B

    Published in Psychopharmacology (Berlin, Germany) (01-01-2015)
    “…Serotonin 5-HT2A and 5-HT2C receptors are thought to be the primary pharmacological mechanisms for serotonin-mediated hallucinogenic drugs, but recently there…”
    Get full text
    Journal Article